tiprankstipranks
AstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment
PremiumCompany AnnouncementsAstraZeneca’s Calquence Gains FDA Approval for First-Line Mantle Cell Lymphoma Treatment
2d ago
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
Premium
The Fly
Drugmakers to push Trump to pause price negotiations, Bloomberg reports
5d ago
Ionis unveils pipeline plan for 2025, expects 4 independent product launches
Premium
The Fly
Ionis unveils pipeline plan for 2025, expects 4 independent product launches
5d ago
AstraZeneca Announces Share Capital and Voting Rights Update
PremiumCompany AnnouncementsAstraZeneca Announces Share Capital and Voting Rights Update
17d ago
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
Premium
The Fly
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
17d ago
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
Premium
Class Action
Levi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
23d ago
AstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
PremiumCompany AnnouncementsAstraZeneca’s Tagrisso Gains EU Approval for Unresectable EGFR-Mutated Lung Cancer
27d ago
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
Premium
Company Announcements
AstraZeneca Strengthens Board with New Non-Executive Director Appointments
1M ago
AstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial
Premium
The Fly
AstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100